כנס ה-EULARי(Rheumatology for Association of Alliance European) הינו ארוע מדעי עולמי לרופאים המטפלים במחלות ראומטולוגיות בכל העולם. להלן סיכום של מאמרים נבחרים שהוצגו במהלך הכנס בנושא דלקת מפרקים שגרונתית.
Key Abstracts from EULAR 2022
D2T RA: How to Achieve Optimal Patient Outcomes
What’s New in Real World Evidence?
Optimization of Treatment in RA
How to Appropriately Assess CV Risk Factors in RA?
General Sessions
Olumiant Therapeutic Indications:
Rheumatoid Arthritis:
Olumiant is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs. Olumiant may be used as monotherapy or in combination with methotrexate.
Atopic Dermatitis:
Olumiant is indicated for the treatment of moderate to severe atopic dermatitis in adult patients who are candidates for systemic therapy. For Full information please see the Israeli MOH approved PI.
CONFIDENTIALITY AND NO FURTHER DISTRIBUTION NOTICE: You are receiving this email because you are a Healthcare Professional (HCP) registered to receive information from Eli Lilly and Company (“Lilly”).
The content of this email is intended for Healthcare Professionals only
© 2022 Eli Lilly Israel. All rights reserved | PP-BA-IL-0442
הירשמו לקבלת עדכונים בנושאים שעלו בכתבה
תגובות אחרונות